Tudor Investment Corp
CYTK icon

Tudor Investment Corp’s Cytokinetics CYTK Stock Holding History

Tudor Investment Corp’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.9M Buy
+92,680
New +$6.65M 0.01% 967
2024
Q3 		– Sell
-74,989
Closed -$4.06M – 2776
2024
Q2 		$4.06M Sell
74,989
-747
-1% -$45.1K 0.02% 740
2024
Q1 		$5.31M Buy
75,736
+40,009
+112% +$3.09M 0.03% 588
2023
Q4 		$2.98M Buy
+35,727
New +$1.29M 0.02% 908
2023
Q2 		– Sell
-32,241
Closed -$1.14M – 2522
2023
Q1 		$1.14M Buy
32,241
+13,878
+76% +$566K 0.02% 1119
2022
Q4 		$841K Sell
18,363
-45,495
-71% -$1.96M 0.02% 1231
2022
Q3 		$3.09M Buy
63,858
+33,154
+108% +$1.6M 0.07% 373
2022
Q2 		$1.21M Buy
+30,704
New +$1.24M 0.03% 778
2021
Q3 		– Sell
-24,317
Closed -$481K – 2517
2021
Q2 		$481K Sell
24,317
-21,475
-47% -$504K 0.01% 1184
2021
Q1 		$1.06M Buy
+45,792
New +$978K 0.02% 804
2017
Q2 		– Sell
-26,166
Closed -$336K – 1090
2017
Q1 		$336K Buy
26,166
+8,926
+52% +$104K 0.01% 935
2016
Q4 		$209K Sell
17,240
-24,060
-58% -$255K 0.01% 1207
2016
Q3 		$379K Buy
41,300
+24,830
+151% +$259K 0.01% 878
2016
Q2 		$156K Buy
16,470
+1,462
+10% +$12K ﹤0.01% 1459
2016
Q1 		$106K Sell
15,008
-12,664
-46% -$92.5K ﹤0.01% 1611
2015
Q4 		$289K Buy
27,672
+8,080
+41% +$79.2K 0.01% 1239
2015
Q3 		$131K Buy
19,592
+2,501
+15% +$17.1K ﹤0.01% 1406
2015
Q2 		$115K Sell
17,091
-7,402
-30% -$48.5K ﹤0.01% 1406
2015
Q1 		$166K Buy
24,493
+11,615
+90% +$86.7K 0.01% 1325
2014
Q4 		$103K Sell
12,878
-1,350
-9% -$5.79K ﹤0.01% 1366
2014
Q3 		$50K Sell
14,228
-24,741
-63% -$104K ﹤0.01% 1302
2014
Q2 		$186K Buy
+38,969
New +$238K 0.01% 1063

Other funds holding CYTK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Tudor Investment Corp's CYTK Position: Q2 2026 in Review

Tudor Investment Corp opened a new position in Cytokinetics (CYTK) in Q2 2026: 92,680 shares worth $7.9M. The stake represents 0.01% of the portfolio and ranks #967 among its holdings. This is a return to the name: Tudor Investment Corp previously reported a position in CYTK as recently as Q2 2024.

Tudor Investment Corp first reported a position in CYTK in Q2 2014 and has held it in 22 quarters since. 483 funds tracked by Wall St. Rank hold CYTK as of Q2 2026.

  • Tudor Investment Corp held 92,680 shares of Cytokinetics worth $7.9M as of Q2 2026.
  • Cytokinetics was a new Tudor Investment Corp position in Q2 2026.
  • Cytokinetics made up 0.01% of Tudor Investment Corp's portfolio in Q2 2026, its #967 holding.
  • Tudor Investment Corp first reported a position in Cytokinetics in Q2 2014 and has held it in 22 quarters since.
  • 483 funds tracked by Wall St. Rank held Cytokinetics as of Q2 2026.

Based on Tudor Investment Corp's 13F filing for Q2 2026, filed 14 Aug 2026.